School of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, 20900, Monza, Italy.
Department of Anesthesia and Intensive Care, IRCCS San Raffaele Hospital, Vita-Salute University, Via Olgettina 60, 20132, Milan, Italy.
Intensive Care Med. 2016 Jan;42(1):72-81. doi: 10.1007/s00134-015-4105-6. Epub 2015 Nov 10.
To evaluate the feasibility and efficacy of an apnea test (AT) technique that combines the application of positive end expiratory pressure (PEEP) with subsequent pulmonary recruitment in a large cohort of brain-dead patients.
This study was a retrospective analysis of prospectively collected data on brain-dead patients admitted to our institution (Hospital San Gerardo, Monza, Italy) between January 2010 and December 2014. The rate of aborted apnea tests (ATs), occurrence of complications (i.e., pneumothorax, cardiac arrhythmias, cardiac arrest, and severe hypoxia, defined as PaO2 < 40 mmHg), ventilator settings, hemodynamics, and blood gas analyses were evaluated. Subgroup analysis was performed, with patients classified into veno-arterial extracorporeal membrane oxygenation (ECMO) or non-ECMO groups, and into hypoxic (i.e., baseline PaO2/FiO2 < 200 mmHg) and non-hypoxic (i.e., baseline PaO2/FiO2 > 200 mmHg) groups.
In total, 169 consecutive patients including 25 on ECMO were included in the study. No AT abortion nor severe complications were detected. The AT was completed in all patients. Fluid boluses and increases or initiation of vasoactive drugs were required in less than 10 and 3% of the AT procedures, respectively. No clinically meaningful alteration in hemodynamics was recorded. Severe hypoxia occurred during 7 (2.4%) and 4 (8%) of the ATs performed in non-ECMO and ECMO patients, respectively (p = 0.063), and it occurred more frequently in hypoxic patients than in non-hypoxic patients (11.1 vs. 4.8%, respectively; p = 0.002).
In a large cohort of consecutive patients, including the largest patient population on ECMO reported to date, our AT technique that combines the application of PEEP with subsequent pulmonary recruitment proved to be feasible and safe.
评估联合应用呼气末正压(PEEP)和随后的肺复张在一大群脑死亡患者中进行窒息试验(AT)的可行性和疗效。
这是一项回顾性分析,对 2010 年 1 月至 2014 年 12 月期间在我院(意大利蒙扎圣杰尔达医院)收治的脑死亡患者前瞻性收集的数据进行分析。评估了窒息试验(AT)中止率、并发症(气胸、心律失常、心脏骤停和严重低氧血症,定义为 PaO2 < 40mmHg)、呼吸机设置、血流动力学和血气分析的发生率。进行了亚组分析,将患者分为静脉-动脉体外膜肺氧合(ECMO)或非 ECMO 组,以及低氧(即基础 PaO2/FiO2 < 200mmHg)和非低氧(即基础 PaO2/FiO2 > 200mmHg)组。
共纳入 169 例连续患者,其中 25 例患者接受 ECMO 治疗。未发现 AT 中止或严重并发症。所有患者均完成了 AT。不到 10%的 AT 过程中需要补液,不到 3%的 AT 过程中需要增加或开始使用血管活性药物。未记录到有临床意义的血流动力学改变。在非 ECMO 和 ECMO 患者中,分别有 7(2.4%)和 4(8%)例 AT 期间出现严重低氧血症(p = 0.063),低氧血症患者比非低氧血症患者更频繁发生(分别为 11.1%和 4.8%;p = 0.002)。
在一个连续的大患者队列中,包括迄今为止报告的最大 ECMO 患者人群,我们联合应用 PEEP 和随后的肺复张的 AT 技术证明是可行和安全的。